Fuda Cancer Hospital, Guangzhou: Breast Neoplasms trials

The registry lists 11 Breast Neoplasms studies with Fuda Cancer Hospital, Guangzhou as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 7Phase 2 9Phase 3 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast CancerWithdrawnNCT03524261Phase 2
• Bioinformation Therapy for Breast CancerCompletedNCT03240224Phase 2/3
• Safety and Efficiency of γδ T Cell Against Breast CancerCompletedNCT03183206Phase 1/2
• Combination of Cryosurgery and NK Immunotherapy for Advanced Breast CancerCompletedNCT02844335Phase 1/2
• Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerCompletedNCT02843126Phase 1/2
• Chimeric Antigen Receptor-Modified T Cells for Breast CancerWithdrawnNCT02547961Phase 1/2
• HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast CancerCompletedNCT02523417Phase 1/2
• Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)CompletedNCT02418481Phase 1/2
• Percutaneous Irreversible Electroportion for Unresectable Breast CancerCompletedNCT02340858Not applicable
• Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma PatientCompletedNCT02338804Phase 1/2
• Safety Study of Cancer Stem Cell Vaccinie to Treat Breast CancerCompletedNCT02063893